1285533-84-7: Sorafenib Deschloro Impurity

1285533-84-7: Sorafenib Deschloro Impurity

Sorafenib Deschloro Impurity (CAS No: 1285533-84-7) Or N-Methyl-4-[4-[[[[3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-2-pyridinecarboxamide, Sorafenib Deschloro is an impurity of Sorafenib,des-chloro-impurities originating from the hydrodehalogenation side reaction, used in treatments of minimizing cancer cell propagation.

Additional information on CAS 1285533-84-7

Catalogue No.

VE008166
CAS No.

1285533-84-7
Molecular Formula

C21H17F3N4O3
Molecular Weight

430.38 g/mol
Parent drug

Sorafenib
IUPAC Name

N-Methyl-4-[4-[[[[3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-2-pyridinecarboxamide
Synonyms

N/A
References

Sci-Hub, Release of a liver anticancer drug, sorafenib from its PVA/LDH- and PEG/LDH-coated iron oxide nanoparticles for drug delivery applications, 10.1038/s41598-020-76504-5. (2020). Retrieved January 21, 2022, from Sci-hub.ee website: https://sci-hub.ee/10.1038/s41598-020-76504-5
Status

In-stock

Other products related to sorafenib

Request a quote

1285533-84-7: Sorafenib Deschloro Impurity

1285533-84-7: Sorafenib Deschloro Impurity
Catalogue No.

VE008166
CAS No.

1285533-84-7
Molecular Formula

C21H17F3N4O3
Molecular Weight

430.38 g/mol
Parent drug

Sorafenib
IUPAC Name

N-Methyl-4-[4-[[[[3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-2-pyridinecarboxamide
Synonyms

N/A
References

Sci-Hub, Release of a liver anticancer drug, sorafenib from its PVA/LDH- and PEG/LDH-coated iron oxide nanoparticles for drug delivery applications, 10.1038/s41598-020-76504-5. (2020). Retrieved January 21, 2022, from Sci-hub.ee website: https://sci-hub.ee/10.1038/s41598-020-76504-5
Status

In-stock
ListName

Sorafenib Deschloro Impurity
Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url